Grown Rogue International (GRUSF) Long-Term Investments (2020 - 2026)
Grown Rogue International (GRUSF) posted quarterly Long-Term Investments of $1.5 million for Q1 2026, down 15.69% year-over-year from $1.7 million in Q1 2025, and up 7.38% quarter-over-quarter from $1.4 million in Q4 2025.
Grown Rogue International (GRUSF) Long-Term Investments (2020 - 2026) Analysis & Trends
Grown Rogue International's Long-Term Investments history runs 5 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Long-Term Investments fell 15.69% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (down 15.69% YoY), while the FY2025 annual figure was $1.4 million, up 135.93% from the prior year.
- Long-Term Investments for Q1 2026 stood at $1.5 million, up from $1.4 million in the prior quarter.
- The five-year high for Long-Term Investments was $2463.2 billion in Q3 2025, with the low at $575967.0 in Q4 2024.
- The 3-year median for Long-Term Investments is $1.5 million (2026), against an average of $307.9 billion.
- The sharpest annual moves came in 2025 and 2026: Long-Term Investments soared 232394022.7% in 2025, then declined 15.69% in 2026.
- Grown Rogue International's Long-Term Investments stood at $575967.0 in 2024, then jumped by 135.93% to $1.4 million in 2025, then increased by 7.38% to $1.5 million in 2026.
- Business Quant data shows GRUSF's Long-Term Investments at $1.5 million in Q1 2026, $1.4 million in Q4 2025, and $2463.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 60.00 Mn |
| 10 | Grown Rogue International | 116.22 Mn | 104.68 Mn | 5.37 Mn | 1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.48 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 2,463.22 Bn |
| Jun 30, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 575,967.00 |
| Sep 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Apr 30, 2021 | 1.45 Mn |
| Jan 31, 2021 | 189,915.00 |
| Oct 31, 2020 | 187,812.00 |
| Jul 31, 2020 | 162,812.00 |
| Apr 30, 2020 | 150,000.00 |